$0.3752
-0.0058-1.52%
Last update: Nov 5, 8:56 AM
PharmaCyte Biotech Inc (PMCB) Stock Price, Quote, News & History
PMCBNASDAQ
PharmaCyte Biotech Inc (NASDAQ: PMCB)
You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.
Other companies in PharmaCyte Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for PharmaCyte Biotech to provide a consensus price target.
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $0.379 last updated November 5, 2026 at 8:56 AM EST.
There are no upcoming dividends for PharmaCyte Biotech.
PharmaCyte Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for PharmaCyte Biotech.
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for...
